These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
230 related articles for article (PubMed ID: 29905864)
1. Pathogenic variant in EPHB4 results in central conducting lymphatic anomaly. Li D; Wenger TL; Seiler C; March ME; Gutierrez-Uzquiza A; Kao C; Bhoj E; Tian L; Rosenbach M; Liu Y; Robinson N; Behr M; Chiavacci R; Hou C; Wang T; Bakay M; Pellegrino da Silva R; Perkins JA; Sleiman P; Levine MA; Hicks PJ; Itkin M; Dori Y; Hakonarson H Hum Mol Genet; 2018 Sep; 27(18):3233-3245. PubMed ID: 29905864 [TBL] [Abstract][Full Text] [Related]
3. Loss of function mutations in EPHB4 are responsible for vein of Galen aneurysmal malformation. Vivanti A; Ozanne A; Grondin C; Saliou G; Quevarec L; Maurey H; Aubourg P; Benachi A; Gut M; Gut I; Martinovic J; Sénat MV; Tawk M; Melki J Brain; 2018 Apr; 141(4):979-988. PubMed ID: 29444212 [TBL] [Abstract][Full Text] [Related]
5. EphrinB2-EphB4 signalling provides Rho-mediated homeostatic control of lymphatic endothelial cell junction integrity. Frye M; Stritt S; Ortsäter H; Hernandez Vasquez M; Kaakinen M; Vicente A; Wiseman J; Eklund L; Martínez-Torrecuadrada JL; Vestweber D; Mäkinen T Elife; 2020 Sep; 9():. PubMed ID: 32897857 [TBL] [Abstract][Full Text] [Related]
6. EphrinB2-EphB4 signals regulate formation and maintenance of funnel-shaped valves in corneal lymphatic capillaries. Katsuta H; Fukushima Y; Maruyama K; Hirashima M; Nishida K; Nishikawa S; Uemura A Invest Ophthalmol Vis Sci; 2013 Jun; 54(6):4102-8. PubMed ID: 23696610 [TBL] [Abstract][Full Text] [Related]
7. Germline Loss-of-Function Mutations in EPHB4 Cause a Second Form of Capillary Malformation-Arteriovenous Malformation (CM-AVM2) Deregulating RAS-MAPK Signaling. Amyere M; Revencu N; Helaers R; Pairet E; Baselga E; Cordisco M; Chung W; Dubois J; Lacour JP; Martorell L; Mazereeuw-Hautier J; Pyeritz RE; Amor DJ; Bisdorff A; Blei F; Bombei H; Dompmartin A; Brooks D; Dupont J; González-Enseñat MA; Frieden I; Gérard M; Kvarnung M; Hanson-Kahn AK; Hudgins L; Léauté-Labrèze C; McCuaig C; Metry D; Parent P; Paul C; Petit F; Phan A; Quere I; Salhi A; Turner A; Vabres P; Vicente A; Wargon O; Watanabe S; Weibel L; Wilson A; Willing M; Mulliken JB; Boon LM; Vikkula M Circulation; 2017 Sep; 136(11):1037-1048. PubMed ID: 28687708 [TBL] [Abstract][Full Text] [Related]
8. ARAF recurrent mutation causes central conducting lymphatic anomaly treatable with a MEK inhibitor. Li D; March ME; Gutierrez-Uzquiza A; Kao C; Seiler C; Pinto E; Matsuoka LS; Battig MR; Bhoj EJ; Wenger TL; Tian L; Robinson N; Wang T; Liu Y; Weinstein BM; Swift M; Jung HM; Kaminski CN; Chiavacci R; Perkins JA; Levine MA; Sleiman PMA; Hicks PJ; Strausbaugh JT; Belasco JB; Dori Y; Hakonarson H Nat Med; 2019 Jul; 25(7):1116-1122. PubMed ID: 31263281 [TBL] [Abstract][Full Text] [Related]
9. SAM domain variants of EPHB4 associated with aberrant signaling are linked to lymphatic-related fetal hydrops and facial dysmorphology. Vanden Broek K; Ryu JR; Perrier R; Tyndall AV; Childs SJ; Au PYB Clin Genet; 2024 Apr; 105(4):386-396. PubMed ID: 38151336 [TBL] [Abstract][Full Text] [Related]
10. PDZ interaction site in ephrinB2 is required for the remodeling of lymphatic vasculature. Mäkinen T; Adams RH; Bailey J; Lu Q; Ziemiecki A; Alitalo K; Klein R; Wilkinson GA Genes Dev; 2005 Feb; 19(3):397-410. PubMed ID: 15687262 [TBL] [Abstract][Full Text] [Related]
11. Lymphatic Malformations: Genetics, Mechanisms and Therapeutic Strategies. Mäkinen T; Boon LM; Vikkula M; Alitalo K Circ Res; 2021 Jun; 129(1):136-154. PubMed ID: 34166072 [TBL] [Abstract][Full Text] [Related]
15. The YAP signaling pathway promotes the progression of lymphatic malformations through the activation of lymphatic endothelial cells. Zhong W; Jiang H; Zou Y; Ren J; Li Z; He K; Zhao J; Zhou X; Mou D; Cai Y Pediatr Res; 2021 Jan; 89(1):110-117. PubMed ID: 32279070 [TBL] [Abstract][Full Text] [Related]
16. Angiogenesis depends upon EPHB4-mediated export of collagen IV from vascular endothelial cells. Chen D; Hughes ED; Saunders TL; Wu J; Vasquez MNH; Makinen T; King PD JCI Insight; 2022 Feb; 7(4):. PubMed ID: 35015735 [TBL] [Abstract][Full Text] [Related]